Refolding Record:
| Protein | |
|---|---|
| Protein Name | Prostasin |
| Abbreviated Name | PRSS8 |
| SCOP Family | Unknown |
| Structure Notes | |
| Organism | Human |
| UniProt Accession | Q16651 |
| SCOP Unique ID | n/a |
| Structure Solved | |
| Class | Unknown |
| Molecularity | Heterodimer |
| Construct | |
|---|---|
| Full Length | n |
| Domain | n/a |
| Chimera | n/a |
| Variants | VAriant 26 |
| Chain Length | 312 |
| Molecular Weight | 33337.8 |
| Pi | 5.39 |
| Molecular Weight | 33337.8 |
| Disulphides | 5 |
| Full Sequence |
AEAPCGVAPQARITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQLDSYSEDAKVSTLKDIIPHPSYLQEGSQGDIALLQLSRPITFSRYIRPICLPAANASFPNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNCLYNIDAKPEEPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPGVYTLASSYASWIQSKVTELQPRVVPQTQESQPDSNLCGSHLAFSSAPAQGLLRPILFLPLGLALGLLSPWLSEH
|
| Notes | n/a |
| Expression | |
|---|---|
| Report | Rickert KW, Kelley P, Byrne NJ, Diehl RE, Hall DL, Montalvo AM, Reid JC, Shipman JM, Thomas BW, Munshi SK, Darke PL, Su HP. (2008) J Biol Chem, 1, 1 |
| Project Aim | Structural Studies |
| Fusion | None |
| Protein Expression and Production | Protein recombinantly expressed as and refolded from inclusion bodies. |
| Expression Host | E coli |
| Expression Strain | BL21(DE3) |
| Expression Temp | 1.0 |
| Expression Time | 1 |
| Expression Vector | n/a |
| Expression Protocol | Bacterial expression constructs contained the original native propeptide sequence at the N-terminus, but with the addition of an enterokinase recognition sequence to allow specific cleavage to generate the active enzyme. Detailed methods for the expression of prostasin in both baculovirus and E. coli are provided in the Supplementary Experimental Procedures |
| Method of Induction | Not Stated |
| Cell Density at Induction | OD n/a = n/a |
| Cell Disruption Method | Not stated |
| Lytic Agent | None |
| Pre-Refolding Purification | Ni-NTA agrose chromatography |
| Solubility | insoluble |
| Refolding | |
|---|---|
| Refolding Method | Column refolding: Nickel-chelating chromatography |
| Wash Buffer | n/a |
| Solubilization Buffer | 8 M urea with 0.1 M Tris/HCl, pH 8.0, and 2 mM DTT |
| Refolding Buffer | 1 M L-arginine, 0.1 M Tris/HCl, 5 mM reduced glutathione, and 0.5 mM oxidized glutathione, pH 8.0 |
| Pre-Refolding Purification | Ni-NTA agrose chromatography |
| Tag Cleaved | no tag |
| Refolding pH | 8.0 |
| Refolding Temperature | 1.0 |
| Protein Concentration | 10.0 mg/L |
| Refolding Time | n/a |
| Redox Agent | GSH/GSSG |
| Redox Agent Concentration | 5/0.5 mM |
| Refolding Protocol | Prostasin variants 26 and 28 (Figure 1) were solubilized from inclusion bodies in 8 M urea with 0.1 M Tris/HCl, pH 8.0, and 2 mM DTT after extensive washing. Solubilized protein was bound to Ni-NTA Superflow resin (Qiagen) and eluted with 0.3 M imidazole. The urea-solubilized material was then refolded in a buffer containing 1 M L-arginine, 0.1 M Tris/HCl, 5 mM reduced glutathione, and 0.5 mM oxidized glutathione, pH 8.0, at a final concentration of 10 mg/L. Following diafiltration, protein was purified via Ni(II) affinity and anion exchange chromatography. Eluted fractions were evaluated via SDS-PAGE and mass spectrometry (MS), and fractions in which prostasin was detected by MS were then pooled for further processing. Prostasin zymogen was converted to the active form by addition of enterokinase (EKMax, Invitrogen) at a final concentration of 2 U/mL (7.5 U/mg prostasin) in the presence of 0.5 mM reduced glutathione. The resultant cleavage reaction was maintained at 4ºC for 48 hours and monitored by MS and SDS-PAGE. Following completion of cleavage as determined by MS, the reaction was incubated at 4ºC overnight after the addition of 1 mM oxidized glutathione. Active prostasin was purified from enterokinase and misfolded prostasin via Ni(II) affinity and anion exchange chromatography. |
| Refolding Assay | SDS-PAGE,enzyme activity |
| Refolding Chaperones | None |
| Refolding Additives | L-Arginine |
| Additives Concentration | 1 M |
| Refolding Yield | n/a |
| Purity | n/a |
| Notes | n/a |